Genstar Names Keith Martino to Strategic Advisory Board
Genstar Names Keith Martino to Strategic Advisory Board
Experienced Pharma Executive to Advise on the Firm's Healthcare Investments
經驗豐富的製藥高管將就公司的醫療保健投資提供建議
SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board. He will advise the Genstar team in its healthcare vertical.
舊金山，2024年4月30日 /PRNewswire/ — 專注於投資醫療保健、金融服務、工業和軟件行業目標細分市場的領先私募股權公司Genstar Capital今天宣佈，任命經驗豐富的製藥業高管基思·馬蒂諾加入其戰略顧問委員會的運營專家團隊。他將爲Genstar團隊提供醫療保健領域的建議。
Mr. Martino has diverse experience working in pharma, consulting, private equity and venture capital. He spent 17 years in pharma with commercial roles at Abbott, AbbVie and Shire (formerly Baxalta) and later was an operating partner with the Vistria Group and Chief Strategy Officer at CareMetx. Most recently, he managed four pharma services businesses within Cardinal Health. Mr. Martino is a graduate of Northwestern University with a B.A. degree in Economics and received his M.B.A. from the University of Chicago Booth School of Business.
Martino先生在製藥、諮詢、私募股權和風險投資領域擁有豐富的經驗。他在製藥行業工作了17年，曾在雅培、艾伯維和夏爾（前身爲巴薩爾塔）擔任商業職務，後來成爲Vistria集團的運營合夥人和CareMetX的首席戰略官。最近，他管理了Cardinal Health旗下的四家制藥服務業務。Martino 先生畢業於西北大學，獲得經濟學學士學位，並獲得芝加哥大學布斯商學院工商管理碩士學位。
Scott Niehaus, Director of Genstar Capital, said, "Keith is highly regarded in the pharma industry and has extensive background across the value chain including working with private equity. Keith brings a tremendous network and complementary skill set, which in partnership with Genstar's existing advisors make him well suited to further build Genstar's healthcare focus. We look forward to Keith's guidance in evaluating new healthcare investment opportunities and advising portfolio companies as a board member." Mr. Martino was named to the Board of Genstar portfolio company Signant Health.
Genstar Capital董事斯科特·尼豪斯表示：“基思在製藥行業備受推崇，在價值鏈中擁有豐富的背景，包括與私募股權合作。Keith擁有龐大的人脈和互補的技能，與Genstar的現有顧問合作，這使他非常適合進一步發展Genstar的醫療保健重點。我們期待Keith在評估新的醫療保健投資機會以及作爲董事會成員爲投資組合公司提供建議方面提供指導。”馬蒂諾先生被任命爲Genstar投資組合公司Signant Health的董事會成員。
A cornerstone of its investment thesis, Genstar's SAB consists of talented current and former C-level operational experts from many of the world's leading companies and industries in which the firm invests.
作爲其投資理念的基石，Genstar的SAB由來自公司投資的許多世界領先公司和行業的現任和前任C級運營專家組成。
About Genstar Capital
Genstar Capital () is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $49 billion of assets under management and targets investments focused on targeted segments of the financial services, industrials, software, and healthcare industries.
關於Genstar Capital
Genstar Capital () 是一家領先的私募股權公司，30多年來一直積極投資高質量的公司。Genstar總部位於舊金山，與其管理團隊和戰略顧問網絡合作，將其投資組合公司轉變爲行業領先的業務。Genstar目前管理着約490億美元的資產，目標投資集中在金融服務、工業、軟件和醫療保健行業的目標細分市場。
Contact: Chris Tofalli
Chris Tofalli Public Relations
914-834-4334
[email protected]
聯繫人：克里斯·託法利
克里斯·託法利公共關係
914-834-4334
[電子郵件保護]
SOURCE Genstar Capital Management, LLC
來源 Genstar 資本管理有限責任公司